Content area

|
|

Methotrexat kan anvendes som steroidbesparendebehandling af svær astma

Astmapatient i anfald.
Forfatter(e)
Malene Knarborg1, Ole Hilberg1 & Ronald Dahl2 1) Lungemedicinsk Afdeling, Aarhus Universitetshospital 2) Allergicentret, Odense Universitetshospital Ugeskr Læger 2014;176:V10130598
Reference: 
Ugeskr Læger 2014;176:V10130598
Blad nummer: 
Sidetal: 
1159-1163
Methotrexate may be a useful corticosteroid reducing treatment of severe asthma
Asthma is a chronic airway disease affecting many people worldwide. Less than 1% suffers from difficult-to-treat asthma and requires systemic corticosteroid treatment to achieve symptom control. The therapeutic options for these patients are limited and often we have to accept a lesser degree of symptom control. Methotrexate has been evaluated in 13 studies, where the mean corticosteroid dose reduction was 35%. Despite the adverse effects, we find that methotrexate may be a useful treatment of severe asthma in certain patients under close observation.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Adam Sinding | 03/07
4 kommentarer
af Helga Schultz | 01/07
2 kommentarer
af H-J Lundsgaard Sørensen | 27/06
1 Kommentar
af Per Fl. Nygaard Andresen | 25/06
27 kommentarer
af Erik Fink Eriksen | 24/06
1 Kommentar